إعلان
إعلان

LUNG

LUNG logo

Pulmonx Corporation Common Stock

2.09
USD
برعاية
-0.12
-5.25%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

2.12

+0.03
+1.43%

تقارير أرباح LUNG

النسبة الإيجابية المفاجئة

LUNG تفوق 20 من 21 آخر التقديرات.

95%

التقرير التالي

بيانات التقرير القادم
١٧ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$22.16M
/
-$0.39
التغير الضمني من Q3 25 (Revenue/ EPS)
+3.07%
/
+14.71%
التغير الضمني من Q4 24 (Revenue/ EPS)
-6.74%
/
+18.18%

Pulmonx Corporation Common Stock earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, LUNG reported earnings of -0.34 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 20.32% surprise. Revenue reached 21.50 مليون, compared to an expected 21.29 مليون, with a 1.02% difference. The market reacted with a -18.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 المحللين forecast an EPS of -0.39 USD, with revenue projected to reach 22.16 مليون USD, implying an زيادة of 14.71% EPS, and زيادة of 3.07% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Pulmonx Corporation Common Stock reported EPS of -$0.34, beating estimates by 20.32%, and revenue of $21.50M, 1.02% above expectations.
The stock price moved down -18.88%, changed from $1.96 before the earnings release to $1.59 the day after.
The next earning report is scheduled for ١٧ فبراير ٢٠٢٦.
Based on 8 المحللين, Pulmonx Corporation Common Stock is expected to report EPS of -$0.39 and revenue of $22.16M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان